Evidence map›Paper›PMID 27708899›Full record

ArticleEuropean journal of rheumatology2014

Serum lipid changes and insulin resistance in familial Mediterranean fever.

Zehra Candan, Ali Akdoğan, Ömer Karadağ, Umut Kalyoncu, Abdurrahman Şahin, Şule Bilgen, Meral Çalgüneri, Sedat Kiraz, Ali Ertenli

Open access · diamondAbstract read
In one paragraph

Article in European journal of rheumatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zehra CandanDepartment of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Ali AkdoğanDepartment of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Ömer KaradağDepartment of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Umut KalyoncuDepartment of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Abdurrahman ŞahinDepartment of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Şule BilgenDepartment of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Meral ÇalgüneriDepartment of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Sedat KirazDepartment of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Ali ErtenliDepartment of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Hacettepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveInflammation is known to alter lipid profiles and to induce insulin resistance. This study was planned to test the hypothesis that familial Mediterranean ferver (FMF) patients and their first-degree asymptomatic relatives may have lipid profile changes and/or insulin resistance, similar to other inflammatory diseases. MATERIAL AND

methodsWe studied 72 FMF patients, 30 asymptomatic first-degree relatives, and 75 healthy controls. Fasting and 2-hour postprandial glucose, insulin, apolipoprotein (Apo) A1, Apo B, acute phase reactants, and lipid profiles of all subjects were studied. Insulin resistance was determined by the HOMA (Homeostasis Model Assessment) index.

resultsThere was no difference between the groups with regard to sex, mean systolic and diastolic blood pressure, body mass index, smoking status, fasting and postprandial 2-hour glucose, insulin, acute phase reactants, and HOMA index levels. High-density lipoprotein cholesterol (HDL-C) levels were similar between FMF patients and FMF relatives (48.9±12.4 mg/dL vs 49.3±13.8 mg/dL; p=NS), and both were lower than controls (48.9±12.4 mg/dL vs 59.6±15.1 mg/dL; p<0.001 and 49.3±13.8 mg/dL vs 59.8±15.1 mg/dL; p=0.001, respectively). Apo A1 levels in FMF patients and asymptomatic first-degree FMF relatives were both lower than in controls, similar to the HDL-C levels (126.1±25.7 mg/dL vs 151.2±31.4 mg/dL; p<0.001 and 129.5±29.0 mg/dL vs 151.2±31.4 mg/dL; p=0.002, respectively). TG levels were significantly higher in FMF relatives as compared to controls (113.4±53.6 mg/dL vs 97.1± 54.9 mg/dL; p=0.025).

conclusionLow HDL-C and low Apo A1 levels are found in FMF patients and their first-degree asymptomatic relatives. Low-grade inflammation caused by MEFV mutations may be responsible for these lipid profile changes.

Indexed as

Familial Mediterranean feverinflammationinsulin resistancelipoproteinMEFV

Identifiers

PMID27708899
PMCPMC5042242
OpenAlexW2164384869

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.